The company initiated a phase II clinical trial in order to demonstrate the drug effectiveness in lung cancer patients.

Zafgen Inc. is the first biopharmaceutical company dedicated to developing novel obesity therapeutics based on vascular targeting in adipose tissue (fat).

AngioGenetics is a start-up drug discovery company focusing on angiogenesis - the formation of new blood vessels.

AngioGenetics is a start-up drug discovery company focusing on angiogenesis - the formation of new blood vessels.

ProQinase covers all aspects of protein kinase targeted drug development. Kinase and angiogenesis assays are a special focus of the service portfolio.

Cancer fighting drugs offer patients the potential relief from their disease. Cancer fighting drugs offer many benefits and work in very different ways. The ...